MedPath
HSA Approval

Infusol NS

SIN13574P

Infusol NS

Infusol NS

November 21, 2008

JOYSON PTE. LTD.

JOYSON PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantJOYSON PTE. LTD.
Licence HolderJOYSON PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

INFUSION, SOLUTION

INTRAVENOUS

Medical Information

B05XA03

sodium chloride

Manufacturer Information

JOYSON PTE. LTD.

Ain Medicare Sdn Bhd

Active Ingredients

Sodium Chloride

0.9% w/v

Sodium chloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Infusol NS - HSA Approval | MedPath